InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Murray Richard /ca/. Director active across 1 company, notably Jounce Therapeutics, Inc.. Cumulatively, 5 filings have been published. Split: 0 buy · 3 sells. Total volume traded: €173k. History available since 7 January 2022. The latest transaction was disclosed on 4 April 2023 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Murray Richard /ca/
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
188,778 sharesCommon StockSEC:0001640455-23-000112:0
39,228 shares@ US$1.8525.5% of flowCommon StockSEC:0001640455-23-000053:0
20,191 shares@ US$1.108.0% of flowCommon StockSEC:0001640455-23-000010:0
87,500 shares0Common StockSEC:0001640455-22-000017:0
13,370 shares@ US$7.3050.0% of flowCommon StockSEC:0001640455-22-000010:0
5 of 5 declarations
About Murray Richard /ca/
MURRAY RICHARD /CA/ is a declarant linked to Jounce Therapeutics, Inc., where he is a Director. He has 7 filings in total. Across the 7 most recent sampled filings, the transactions are sales, for a total of EUR 259850, between 2022-01-11 and 2023-05-04.
